Skip to content

Art Therapy to Treat Women With Fibromyalgia

Assessment of Art Therapy Program for Women With Fibromyalgia: Randomized, Controlled, Blinded Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01586637
Enrollment
80
Registered
2012-04-27
Start date
2011-01-31
Completion date
2012-01-31
Last updated
2012-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Fibromyalgia, Art Therapy, Pain, Quality of life, Body Image

Brief summary

Effectiveness of an art therapy program for the treatment of pain and improvements in both quality of life and body image of patients with fibromyalgia.

Detailed description

Fibromyalgia (FM) is a chronic non-inflammatory syndrome characterized by diffuse pain throughout the body, sleep disorder, stiffness, fatigue, depression and other psychological problems. Patients with FM feel incapable of performing the majority of activities of daily living. Medication offers only short-term benefits. Thus, it is necessary to include other measures for treatment, such as physical activity and patient education. Art therapy combine the field of psychology with artistic activities, working with therapeutic and instructive aspects as well as the potential for personal growth contained in all forms of art.

Interventions

OTHERArt Therapy

This group performed dance classes and regarding the art therapy they have art classes where they learn how to use the drawing to express feelings. The classes were twice a week.

OTHERWalking

The group walked twice a week during one hour.

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Classification of fibromyalgia by ACR criteria (Wolf et al, 1990) * Females * Without distinction of race * Age 18 to 65 years * Do not have changed treatment for fibromyalgia for at least 3meses * signing the consent form

Exclusion criteria

* Other ostearticulares rheumatic and painful * Decompensated cardio-respiratory diseases * Perform physical activity more than 2x a week for more than 3 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Painbaseline, after 10 weeks, 20 weeks and 40 weeksEvaluated with the visual analogue scale

Secondary

MeasureTime frameDescription
Change in fibromyalgia impactBaseline, after 10, 20 and 40 weeksEvaluated using the Fibromyalgia Impact Questionnaire
Change in Quality of lifeBaseline, after 10, 20 and 40 weeksEvaluated using the SF-36 questionnaire
Change in Body imageBasline, after 10, 20 and 40 weeksEvaluated using the Body Dismorphic Disorder Examination (BDDE) questionnaire
Change in Functional capacityBaseline, after 10, 20 and 40 weeksEvaluated using the six minute walk test

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026